Latest Articles
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer - Pharmacy Times
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer Pharmacy Times
Published: Oct. 21, 2025, 3:34 a.m.
Endometriosis rates double in 10 years, new research reveals - bodyandsoul.com.au
Endometriosis rates double in 10 years, new research reveals bodyandsoul.com.au
Published: Oct. 21, 2025, 1:04 a.m.
The mistake at the piano that became a song of healing for countless women - The Age
The mistake at the piano that became a song of healing for countless women The Age
Published: Oct. 21, 2025, 12:29 a.m.
Study reveals significant increase in diagnosis of endometriosis in women attending Australian general practice - Monash University
Study reveals significant increase in diagnosis of endometriosis in women attending Australian general practice Monash University
Published: Oct. 21, 2025, 12:02 a.m.
Lo Bosworth Reveals She Had Endometriosis Surgery Just 8 Weeks After Her Fiancé Had Double-Jaw Surgery: 'We've Been Through a Lot' (Exclusive) - MSN
Lo Bosworth Reveals She Had Endometriosis Surgery Just 8 Weeks After Her Fiancé Had Double-Jaw Surgery: 'We've Been Through a Lot' (Exclusive) MSN
Published: Oct. 20, 2025, 11:56 p.m.
Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO - Citeline News & Insights
Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO Citeline News & Insights
Published: Oct. 20, 2025, 10:35 p.m.
How BNDD stock moves in volatile trading sessions - 2025 Investor Takeaways & Low Risk Growth Stock Ideas - nchmf.gov.vn
How BNDD stock moves in volatile trading sessions - 2025 Investor Takeaways & Low Risk Growth Stock Ideas nchmf.gov.vn
Published: Oct. 20, 2025, 9:37 p.m.
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women - VOI.ID
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women VOI.ID
Published: Oct. 20, 2025, 9:35 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal
Published: Oct. 20, 2025, 9:33 p.m.
Global Study Reports Rise in Several Cancers Among Adults of All Ages - MedPage Today
Global Study Reports Rise in Several Cancers Among Adults of All Ages MedPage Today
Published: Oct. 20, 2025, 9:27 p.m.
Link copied to clipboard!